Establishment of an indocyanine green test using an automatic chemistry analyzer
-
Moon-Woo Seong
Abstract
The indocyanine green (ICG) clearance test has been used to assess the reserve of hepatic function. This method is based on the spectrometric measurement of its plasma concentration at maximum wavelength of 805nm, which requires a spectrophotometer and associated maintenance. We established an ICG clearance test using a Toshiba 200FR automatic chemistry analyzer that can be tuned to a wavelength of approximately 805nm. Five pooled sera spiked from 0 to 4.0mg/dL were analyzed for linearity test and precision was determined at five levels in the range 0.1–2.0mg/dL. The ICG retention rate at 15min (R15) was determined for 38 patients using a conventional method and our method. The ICG clearance test using the automatic chemistry analyzer showed good linearity, and precision ranged from 0.3% to 1.0% for within-run CVs and from 0.6% to 4.7% for total CVs. The degree of agreement between the two methods was also acceptable (mean difference of 1.5%). It is expected that the ICG test using the automatic chemistry analyzer can replace the conventional ICG clearance test, considering the excellent agreement, good precision and linearity over a clinically relevant range.
References
1. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005; 12:16–22.10.1007/s00534-004-0965-9Search in Google Scholar
2. Kim S, Park R, Lee KR, Kim JH, Kwon OH. Comparison of the indocyanine green clearance test using conventional blood sampling and finger monitoring methods. Korean J Lab Med 2003; 23:88–91.Search in Google Scholar
3. Maarek JM, Holschneider DP, Harimoto J, Yang J, Scremin OU, Rubinstein EH. Measurement of cardiac output with indocyanine green transcutaneous fluorescence dilution technique. Anesthesiology 2004; 100:1476–83.10.1097/00000542-200406000-00020Search in Google Scholar
4. Mitra S, Chamney P, Greenwood R, Farrington K. Serial determinations of absolute plasma volume with indocyanine green during hemodialysis. J Am Soc Nephrol 2003; 14:2345–51.10.1097/01.ASN.0000082998.50730.FASearch in Google Scholar
5. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995; 169:589–94.10.1016/S0002-9610(99)80227-XSearch in Google Scholar
6. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 2004; 10:S39–45.10.1002/lt.20040Search in Google Scholar
7. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003; 110:15–21.10.1016/S0161-6420(02)01563-4Search in Google Scholar
8. Tsubono T, Todo S, Jabbour N, Mizoe A, Warty V, Demetris AJ, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996; 24:1165–71.10.1002/hep.510240531Search in Google Scholar
9. Wakabayashi H, Ishimura K, Izuishi K, Karasawa Y, Maeta H. Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma. J Surg Res 2004; 116:248–52.10.1016/j.jss.2003.09.015Search in Google Scholar
10. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960; 39:592–600.10.1172/JCI104072Search in Google Scholar
11. Owen VM. Estimation of indocyanine green concentrations. Clin Biochem 1973; 6:132–5.10.1016/S0009-9120(73)80022-0Search in Google Scholar
12. Landsman ML, Kwant G, Mook GA, Zijlstra WG. Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol 1976; 40:575–83.10.1152/jappl.1976.40.4.575Search in Google Scholar PubMed
13. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84:1255–9.Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
